SYNTARGA
Syntarga is a privately held biopharmaceutical company engaged in the discovery and development of proprietary Antibody-Drug Conjugate technology and products for the treatment of cancer. The Company's cutting-edge chemistry capabilities and unique know-how have led to the creation of its antibody empowering Potent Payload Technology. Syntarga is leveraging its proprietary technologies and expertise to generate and commercialize, alone and with partners, a portfolio of next generation Antibody-Drug Conjugate products.
SYNTARGA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2002-01-01
Address:
Nijmegen, Gelderland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.syntarga.com
Total Employee:
1001+
Status:
Active
Contact:
+31 24 372 7700
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF DoubleClick.Net Nginx CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains EuroDNS DNS
Similar Organizations
Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.
GlycoDesign
GlycoDesign is a biopharmaceutical company, engages in the discovery and development of proprietary drugs for the treatment.
multimmune GmbH
multimmune GmbH, a biopharmaceutical company, engages in the discovery and development of novel products.
Current Employees Featured
Founder
Investors List
PPM Oost NV
PPM Oost NV investment in Venture Round - Syntarga
Official Site Inspections
http://www.syntarga.com
- Host name: 185.53.177.20
- IP address: 185.53.177.20
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Syntarga"
Syntarga Company Profile | Management and Employees List
Syntarga is a privately held biopharmaceutical company engaged in the discovery and development of proprietary Antibody-Drug Conjugate technology and products for the …See details»
Syntarga Company Profile 2024: Valuation, Investors, Acquisition ...
Syntarga was founded in 2002. Who is the founder of Syntarga? Vincent de Groot Ph.D is the founder of Syntarga. Where is Syntarga headquartered? Syntarga is headquartered in …See details»
Syntarga - Overview, News & Similar companies | ZoomInfo.com
Syntarga is a privately held biopharmaceutical company engaged in the discovery and development of proprietary Antibody-Drug Conjugate technology a nd products for the …See details»
Syntarga - Company Profile - Tracxn
Syntarga ranks 1,858th among 2439 active competitors. 865 of its competitors are funded while 580 have exited. Overall, Syntarga and its competitors have raised over $82B in funding …See details»
Syntarga - VentureRadar
"Syntarga B.V. is a biopharmaceutical company creating innovative chemistries to link anticancer activity to specificity. The Company develops highly potent cell-killing drugs, releasable linker …See details»
Syntarga - Products, Competitors, Financials, Employees, …
Syntarga is a privately held company focused on the development of chemistries that link antibodies with cytotoxic drugs in order to target and eliminate cancer cells more effectively. …See details»
Syntarga BV - Drug pipelines, Patents, Clinical trials - Synapse
Explore Syntarga BV with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:Antibody drug conjugate (ADC), Drug:ADCs …See details»
Syntarga - Funding, Financials, Valuation & Investors - Crunchbase
Syntarga is a privately held biopharmaceutical company engaged in the discovery and development of proprietary Antibody-Drug Conjugate. Search Crunchbase. Start Free Trial . …See details»
Syntarga - Crunchbase
Syntarga is a privately held biopharmaceutical company engaged in the discovery and development of proprietary Antibody-Drug Conjugate. Search Crunchbase. Start Free Trial . …See details»
Syntarga BV - Nimwegen, Netherlands - bionity.com
Syntarga B.V. is a biopharmaceutical company creating innovative chemistries to link anticancer activity to specificity. The Company develops highly potent cell-killing drugs, releasable linker …See details»
Syntarga B.V. Overview | SignalHire Company Profile
Syntarga B.V. is a biopharmaceutical company creating innovative chemistries to link anticancer activity to specificity. The Company develops highly potent cell-killing drugs, releasable linker …See details»
Syntarga Management Team - CB Insights
Explore {Syntarga's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Syntarga CEO, Founder, Key …See details»
Syntarga BV Company Profile- Outlook, Business Segments, …
'Syntarga BV Company Profile' is a complete analysis of the company's operations, strategies, outlook and historic performance. The research work analyzes key strategies ... statement, …See details»
Syntarga - Contacts, Employees, Board Members, Advisors & Alumni
Syntarga is a privately held biopharmaceutical company engaged in the discovery and development of proprietary Antibody-Drug ConjugateSee details»
Syntarga Announces Two Antibody-Drug Conjugate …
Syntarga B.V., the emerging Antibody-Drug Conjugate (ADC) company, announces today that it entered into research collaborations with two undisclosed top-15 pharma companies. These …See details»
ADCs directed against HER2(Syntarga) - Drug Targets, Indications ...
Literatures (Medical) associated with ADCs directed against HER2(Syntarga) 15 Oct 2024 · CLINICAL CANCER RESEARCH HER2 Antibody–Drug Conjugates Are Active against …See details»
BYON-3521 - Drug Targets, Indications, Patents - Synapse - Patsnap
Dec 12, 2024 BYON3521 Targets c-MET, Widely Overexpressed in Solid Tumors Therapy Uses Proprietary Technologies Designed to Enhance Efficacy and Safety NIJMEGEN, Netherlands, …See details»
Syntarga - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Syntarga is a privately held biopharmaceutical company engaged in the discovery and development of proprietary Antibody-Drug Conjugate. Search Crunchbase. Start Free Trial . …See details»
Org Chart Sentara Healthcare - The Official Board
The organizational chart of Sentara Healthcare displays its 41 main executives including Dennis Matheis, Robert Broermann, Aubrey Layne and Nancy ButlerSee details»